These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28420891)

  • 21. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does dual-time-point
    Wu B; Zhao Y; Zhang Y; Tan H; Shi H
    Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
    Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH
    Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
    Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J
    Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
    Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
    Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M; Ayabe T; Tsuchiya K; Nakamura K
    Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing between Thymic Epithelial Tumors and Benign Cysts via Computed Tomography.
    Lee SH; Yoon SH; Nam JG; Kim HJ; Ahn SY; Kim HK; Lee HJ; Lee HH; Cheon GJ; Goo JM
    Korean J Radiol; 2019 Apr; 20(4):671-682. PubMed ID: 30887749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
    Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
    J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
    Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
    Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
    Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?
    Lococo F; Cesario A; Treglia G
    Ann Nucl Med; 2014 Jul; 28(6):593-4. PubMed ID: 24728730
    [No Abstract]   [Full Text] [Related]  

  • 34. The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
    Otsuka H
    J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reply to 'Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?'.
    Chida M; Sakamoto S
    Ann Nucl Med; 2014 Jul; 28(6):595-6. PubMed ID: 24728731
    [No Abstract]   [Full Text] [Related]  

  • 36. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
    Lee G; I H; Kim SJ; Pak K; Cho JS; Jeong YJ; Lee CH; Chang S
    Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
    Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
    Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
    Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Yabuuchi H; Matsuo Y; Abe K; Baba S; Sunami S; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Nagao M; Okamoto T; Nakamura K; Yamamoto H; Sasaki M; Honda H
    Clin Radiol; 2015 Nov; 70(11):1289-98. PubMed ID: 26272529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.